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Abstract
Background Frameless stereotactic biopsies are replacing
frame-based stereotaxy as a diagnostic approach to brain
lesions. In order to avoid a sampling bias or negative histol-
ogy, multiplespecimens are often taken.This inturnincreases
the risk of hemorrhagic complications.
Objective We present the use of 5-aminolevulinic acid (5-
ALA)-induced protoporphyrin IX fluorescence in frameless
stereotaxy to improve the procedure duration and yield, and
thereby reduce the risk of complications.
Methods Patients with suspected high-grade brain tumors
are given 5-ALA 4 h prior to stereotactic biopsy. The biopsy
needle is guided to the target using frameless stereotaxy
based either on preoperative images or combined with intra-
operative MRI sequences. The specimen is illuminated with
blue light to look for fluorescence. In case of a positive
fluorescence within the tissue sample, no frozen sections are
obtained, and no further specimens are taken.
Results The samples of 13 patients revealed a positive
fluorescence and were histologically confirmed as malig-
nant or high-grade brain neoplasms. four cases were
fluorescence-negative, requiring frozen section confirmation
and/or multiple samples. In theses cases histology was either
nonspecific gliotic changes or low-grade tumors. There were
no complications related to the additional use of 5-ALA.
Conclusion 5-ALA fluorescence in stereotactic biopsies can
increase the safety and accuracy of these procedures by
reducing sampling errors and eliminating the need for mul-
tiple samples and/or frozen section verification, creating a
more accurate, faster and safer procedure for cases of sus-
pected malignant or high-grade brain tumors situated in
deep or eloquent areas.
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Introduction
Over the last few years, frameless stereotactic biopsies have
progressively replaced frame-based stereotactic procedures
as a first line diagnostic approach to various brain lesions.
The combined use of intraoperative magnetic resonance
imaging (MRI) further increases the spatial resolution of
the probe target correlation in these procedures [7]. Yet,
despite the increasing accuracy of frameless stereotactic
procedures, failure to correctly establish tumor histology
and dignity occurs in approximately 25% of cases, mainly
due to tissue heterogeneity and sampling bias [3, 7]. In cases
where the frameless stereotactic biopsy is based solely on
preoperative computertomographic (CT) or MRI images,
the results are even less favorable with 37% [1] to 49% [5]
of incorrectly diagnosed gliomas. In order to avoid sampling
bias, obtaining multiple specimens has been advocated [12].
Since stereotactic procedures are the diagnostic method of
choice for deep-seated lesions, within the brain stem, or
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ples during the same procedure to improve the diagnostic
accuracy can be risky or even impossible. A precise histo-
logical diagnosis, however, is crucial for appropriate treat-
ment guidance and prognosis. To decrease the morbidity
and mortality risks associated with multiple sampling, we
introduced fluorescence-controlled stereotaxy in our depart-
ment [4]; additional cases were published in support of the
concept by others [8]. We here present a series of 17 con-
secutive patients where we combined 5-aminolevulinic acid
(5-ALA)-induced fluorescence with frameless stereotaxy for
r a p i db i o p s ya c c u r a c yv e r i f i c ation in cases of suspected
malignant or high-grade brain tumors.
Methods
Four hours prior to surgery the patient is given an oral dose
of a 20-mg/kg body weight aqueous solution of 5-
aminolevulinicacidhydrochloride(Gliolan® medac GmbH,
Hamburg, Germany) [11]. The MRI data used for biop-
sy planning and guidance are obtained either preopera-
tively using a standardized high-resolution imaging
protocol or, if available, intraoperatively after the patient
has been positioned on the operating table. After general
anesthesia, burr hole placement and dural opening at the
determined entry point are performed in the usual fash-
ion. Using frameless stereotaxy navigation (StealthStation®,
Medtronic, Louisville, KY, USA), the biopsy needle is then
advancedintothetargetedlesion,guidedbytheMRIdata,and
a first sample is taken. After removal of the needle it is placed
under a 405–440-nmbluelightsource(either adedicated light
sourceorthe light sourceofanoperating microscopefitted for
5-ALA-induced PpIX fluorescence) with the specimen still in
place to look for fluorescence. In case of strong positive
fluorescence, no frozen section is obtained, and no further
samples are taken.
Illustrative case
A 71-year-old male (Table 1, case 01) with multiple intra-
cerebral lesions of unknown origin underwent a frameless
stereotactic biopsy in the periventricular area of the right
frontal horn. As a proof of concept, the accuracy of the
calculations and needle placement was verified by obtaining
an intraoperative MRI scan with the titanium biopsy needle
(Pajunk Medizintechnologie, Geisingen, Germany) still in
place. After removal of the needle and blue light illumina-
tion of the tissue sample, a positive red fluorescence could
be observed. As the opening of the biopsy needle (10 mm)
was larger than the target lesion (5 mm), and the needle
itself has a 2-mm forerun (Fig. 1, top), only the distal part of
the actual specimen was expected to hold pathological
tissue, which was confirmed by visible 5-ALA-induced
protoporphyrin IX (PpIX) fluorescence only within the
tumor tissue (Fig. 1, bottom). Histology and immunohisto-
chemistry revealed a malignant lymphoma (B-cell lympho-
ma), and showed the border between the target lesion and the
surrounding brain (Fig. 2) as predicted by fluorescence and
MRI.
Results
Seventeen biopsies using a combination of frameless
stereotaxy and 5-ALA-induced fluorescence were per-
formed (Table 1). In 13 cases a positive fluorescence
was detected and histological examination confirmed a
malignant or high-grade brain neoplasm in all cases.
The specimens of the remaining four biopsies were
Table 1 Demographic data, detected fluorescence and final pathology
of 17 patients who underwent a frameless stereotactic brain biopsy
after oral administration of Gliolan® (5-ALA). Fluorescence was
assessed under a 440-nm blue light source
Patient Sex Age
(years)
Fluorescence Final histology
01 M 71 Positive B-cell lymphoma
02 M 60 Positive Glioblastoma
multiforme
03 M 79 Positive Glioblastoma
multiforme
05 M 70 Positive Glioblastoma
multiforme
07 F 38 Positive B-cell lymphoma
09 M 25 Positive Germinoma
10 M 49 Positive Astrocytoma WHO
grade III
11 F 72 Positive Astrocytoma WHO
grade III
12 F 76 Positive B-cell lymphoma
13 M 65 Positive B-cell lymphoma
15 M 72 Positive Glioblastoma
multiforme
16 M 65 Positive Glioblastoma
multiforme
17 F 39 Positive Glioblastoma
multiforme
04 M 30 Negative Astrocytoma WHO
grade II
06 F 71 Negative Astrocytoma WHO
grade II
08 M 52 Negative Unspecific gliosis
14 M 82 Negative Unspecific gliosis
Age in years, M0male, F0female.
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tion and/or further samples. In these cases histology showed
either nonspecific gliotic changes or low-grade tumors, both
of which are known not to induce any fluorescence after
5-ALA application.
In the fluorescence-positive cases the procedure time
could be reduced by 30–45 min, since no frozen sections
needed to be obtained and no resampling was necessary.
In this small series of patients there were no complica-
tions related either to the use of 5-ALA or to the surgical
procedure itself.
Discussion
Stereotactic brain biopsies carry a morbidity and mortality
risk of 4% and 0.9%, respectively, and lead to an inaccurate
or imprecise diagnosis in one third to one half of glioma
cases [5]. Further improvement can be achieved by obtain-
ing multiple specimens and/or the additional use of intra-
operative imaging [7]. Since patients with malignant
gliomas fare better with gross total resection [6], bioptic
procedures are usually limited to inoperable or small lesions
thataredeeplylocated(e.g.,brainstem)orsituatedineloquent
corticalareas.Unfortunately, these typical areas for biopsy are
the least suitable for multiple tissue sampling. Intraoperative
frozen sections can aid the neurosurgeon in verifying the
adequate biopsy sampling location, but they are time consum-
ing and also prone to errors.
5-ALA is a non-fluorescent “pro-drug” that, due to a
metabolism disturbance, is transformed into fluorescent
PpIX in the tumor cells of high-grade gliomas [10]a n d
other highly proliferative neoplasms. This property is used
to achieve radical tumor resection and thereby extend
progression-free survival in high-grade glioma patients
[11]. In the case of stereotactic brain biopsy, the use of
protoporphyrin fluorescence does not aim at optimal resec-
tion, but allows the procedure to be time-efficient and as
minimally invasive as possible by reducing the risk of
multiple tumor samplings. The sensitivity and specificity
of malignant tissue detection have been reported to be
85% and 100%, respectively [2]. The PPV of observable
intraoperative PpIX fluorescence for non-normal tissue is
found to be as high as 98.9% [9]. Therefore, a sample
showing strong positive fluorescence most likely represents
the targeted lesion. Although we used intraoperative MR
imaging (PoleStar N20®, Medtronic, Yokneam Elit, Israel)
for navigation to assess the accuracy of the method de-
scribed and to rule-out an acute hemorrhagic complication,
the same methodology is applicable to frameless stereotactic
procedures based on preoperative CT or MR images, the
main purpose being that no further samplings are required in
case of a positive fluorescence.
Negative fluorescence can either be due to a sampling
error (small lesion, preoperative imaging not accounting for
brain shift) or to the histological nature of the pathology
(non-fluorescent tumor or lesion). In these cases frozen
sections are required to assess the adequacy of the sampling
location; if available, intraoperative imaging can also be
used to correct the needle position relative to the intended
target and can be of invaluable help in very small lesions.
Conclusion
The addition of 5-ALA-induced PpIX fluorescence proved
useful in frameless stereotactic biopsies of malignant or
high-grade brain tumors where immediate strong intraoper-
ative fluorescence was observed. The procedure time could
be reduced and its safety increased by eliminating the need
for multiple samples. In these cases frozen section veri-
fication may not be mandatory, since the final pathology
was conclusive in all instances of positive fluorescence.
The method is easy to implement and requires no mod-
ification to the biopsy procedure itself. Fluorescence-
negative cases represent either a missed target or a non-
fluorescentpathology,andthereforedorequirefrozensections
Fig. 1 The opening of the biopsy needle (10 mm) is larger than the
target lesion (5 mm), and the needle itself has a 2-mm fore-run (Fig. 1,
top). Only the distal part of the actual specimen was expected to hold
pathological tissue, which was confirmed by visible 5-ALA-induced
protoporphyrin IX (PpIX) fluorescence only within the tumor tissue
(Fig. 1, bottom)
Fig. 2 Immunohistochemistry revealed a malignant lymphoma (B-cell
lymphoma), and showed the border between the target lesion and the
surrounding brain (CD 20)
Acta Neurochir (2012) 154:585–588 587and/or intraoperative imaging to verify the adequacy of the
sampled target.
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Comment
The authors obtained frameless stereotactic needle biopsies from brain
lesions of 17 patients 4 h after 5-ALA administration. In the operating
room, biopsy samples still in the needle were placed under blue light
(405–440 nm), which is generally available on operation microscopes
fitted for the 5-ALA method. Samples of 13 tumors became pink, and
all 13 were histologically malignant. The practical point is—taken that
pink almost always indicates a malignant tumor—that no further sam-
ples are needed after a pink one. The authors saved 30 to 45 min of
procedure time, not needing to wait for frozen section diagnoses and
not taking more samples. This is a clever diagnostic extension of the 5-
ALA method.
In the next wave of intraoperative diagnostics with biologically
targeted fluorescent molecules, we should have light sources in the
operation microscopes that provide illumination and excitation at de-
sired and changeable wave length bands, and we should have spectral
analysis tools to better distinguish diagnostic fluorescence among the
light that reflects/scatters from the tissues in the operative field.
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